Wu Z - Search Results

1

Blood-brain barrier remodeling in an organ-on-a-chip device shows Dkk1 to be a regulator of early metastasis.

Westerhof TM, Yang BA, Merill NM, Yates JA, Altemus M, Russell L, Miller AJ, Bao L, Wu Z, Ulintz PJ, Aguilar CA, Morikawa A, Castro MG, Merajver SD, Oliver CR. Westerhof TM, et al. Among authors: wu z. Adv Nanobiomed Res. 2023 Apr;3(4):2200036. doi: 10.1002/anbr.202200036. Epub 2023 Feb 5. Adv Nanobiomed Res. 2023. PMID: 37234365 Free PMC article.

2

A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic niche.

Oliver CR, Altemus MA, Westerhof TM, Cheriyan H, Cheng X, Dziubinski M, Wu Z, Yates J, Morikawa A, Heth J, Castro MG, Leung BM, Takayama S, Merajver SD. Oliver CR, et al. Among authors: wu z. Lab Chip. 2019 Mar 27;19(7):1162-1173. doi: 10.1039/c8lc01387j. Lab Chip. 2019. PMID: 30810557 Free PMC article.

3

IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling.

Little AC, Pathanjeli P, Wu Z, Bao L, Goo LE, Yates JA, Oliver CR, Soellner MB, Merajver SD. Little AC, et al. Among authors: wu z. Front Oncol. 2019 May 31;9:456. doi: 10.3389/fonc.2019.00456. eCollection 2019. Front Oncol. 2019. PMID: 31214501 Free PMC article.

4

Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes.

Altemus MA, Goo LE, Little AC, Yates JA, Cheriyan HG, Wu ZF, Merajver SD. Altemus MA, et al. PLoS One. 2019 Sep 19;14(9):e0220973. doi: 10.1371/journal.pone.0220973. eCollection 2019. PLoS One. 2019. PMID: 31536495 Free PMC article.

5

RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers.

Abraham HG, Ulintz PJ, Goo L, Yates JA, Little AC, Bao L, Wu Z, Merajver SD. Abraham HG, et al. Among authors: wu z. Front Oncol. 2021 Aug 26;11:712041. doi: 10.3389/fonc.2021.712041. eCollection 2021. Front Oncol. 2021. PMID: 34513691 Free PMC article.

6

Rho proteins and cell-matrix interactions in cancer.

Wu M, Wu ZF, Merajver SD. Wu M, et al. Cells Tissues Organs. 2007;185(1-3):100-3. doi: 10.1159/000101309. Cells Tissues Organs. 2007. PMID: 17587814 Review.

7

RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells.

Wynn ML, Yates JA, Evans CR, Van Wassenhove LD, Wu ZF, Bridges S, Bao L, Fournier C, Ashrafzadeh S, Merrins MJ, Satin LS, Schnell S, Burant CF, Merajver SD. Wynn ML, et al. J Biol Chem. 2016 Jun 24;291(26):13715-29. doi: 10.1074/jbc.M115.703959. Epub 2016 Apr 25. J Biol Chem. 2016. PMID: 27129239 Free PMC article.

8

Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.

Allen SG, Chen YC, Madden JM, Fournier CL, Altemus MA, Hiziroglu AB, Cheng YH, Wu ZF, Bao L, Yates JA, Yoon E, Merajver SD. Allen SG, et al. Sci Rep. 2016 Dec 19;6:39190. doi: 10.1038/srep39190. Sci Rep. 2016. PMID: 27991524 Free PMC article.

9

Heterogeneity at the invasion front of triple negative breast cancer cells.

Aw Yong KM, Ulintz PJ, Caceres S, Cheng X, Bao L, Wu Z, Jiagge EM, Merajver SD. Aw Yong KM, et al. Among authors: wu z. Sci Rep. 2020 Apr 1;10(1):5781. doi: 10.1038/s41598-020-62516-8. Sci Rep. 2020. PMID: 32238832 Free PMC article.

10

Loss of PTEN promotes formation of signaling-capable clathrin-coated pits.

Rosselli-Murai LK, Yates JA, Yoshida S, Bourg J, Ho KKY, White M, Prisby J, Tan X, Altemus M, Bao L, Wu ZF, Veatch SL, Swanson JA, Merajver SD, Liu AP. Rosselli-Murai LK, et al. J Cell Sci. 2018 Apr 26;131(8):jcs208926. doi: 10.1242/jcs.208926. J Cell Sci. 2018. PMID: 29588397 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34,966 results

Search Page